Bausch Health Companies (BHC)

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.

If you are interested in BHC stock information, you might also be interested in competitors like OTCPK:ESMC.

The market capitalization of Bausch Health Companies is currently at $1.87 B. This places it among the low capitalized companies.

With one share of Bausch Health Companies investors achieved a dividend of $0.00. This results in a very low dividend yield of 0.00%.

For the risk analysis, the high beta factor should be noted, which is currently at a value of 1.34. The price of the stock NYSE:BHC is therefore subject to relatively strong fluctuations in relation to the overall market.

17.1% of BHC Stocks is owned by insiders.

For Wall Street analysts, a price target of $34.09 is currently considered realistic.

NYSE:BHC has a 52 week range of $4.00 - $29.59 and is currently trading around $4.62.

The low short sale ratio indicated that the value might increase in the foreseeable future.